Fido and Fluffy are getting their paws on more of their humans' prescription medicines these days. Dogs follow their noses to gelatin-based capsules and flavored drugs, while cats prefer the antidepressant Effexor. Report
| Tuesday, February 23 | 2pm ET / 11am PT | Presented By: BBK Worldwide
Join the National Organization for Rare Disorders (NORD), Xenon Pharmaceuticals and BBK Worldwide as they take a closer look at the challenges and opportunities in rare disease clinical R&D. Registration is free – click here.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!